Create a narrative

Merck Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Merck

WA

Based on Analyst Price Targets

Advancing New Therapies And Expanding Global Markets Pave The Way For Long-Term Growth And Innovation

Key Takeaways Expanding product pipeline and R&D investments aim to boost revenue, long-term growth, and market share in key therapeutic areas. Ongoing demand for KEYTRUDA and strategic vaccine expansion anticipate robust revenue growth and improved market presence globally.

US$131.08

FV

24.3% undervalued

5.59%

Revenue growth p.a.

1

0

40

3 days ago

No data found for this company